Similarly, genetic deletion of a negative regulator of IL-15 signaling, called cytokine-inducible SH2-containing protein or CIS, in iPSC-NK cells led to improved anti-tumor function, both in vitro and in vivo in a leukemia xenograft model [162]. This evidence concerns the gene IL15 and neoplasm.